NASH: Current and future therapies With Prof. Philip Newsome

This is a special episode brought to you in association with Hepatology Knowledge into Practice. NASH has historically had very few treatment options, with none currently indicated specifically for NASH. But a large number of ongoing clinical trials means that treatment may look different in the future. Join Professor Philip Newsome for an overview of current treatments in NASH, as well as how treatment may change in the future. By completing this activity you can qualify for 0.25 CME credits. To claim your credits, you must listen to the podcast and successfully pass the post-module assessment at diabetes.knowledgeintopractice.com, where you can find all past episodes of the podcast as well as other free CME resources. References: References are available here Disclosures: Prof. Philip Newsome declares the following: Consultant on behalf of the University of Birmingham: Boehringer Ingelheim, Novo Nordisk, Intercept, BMS, Gilead, Poxel Pharmaceuticals Grants/Research Support recipient: Novo Nordisk, Boehringer Ingelheim Liberum IME staff, ACHL staff and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose. The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity. Target Audience This educational activity is intended for an international audience of non-US and non-UK HCPs. Funding: This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education.

You can listen to NASH: Current and future therapies With Prof. Philip Newsome online on Radio and Podcast. Open the player on this page to stream the available audio.

NASH: Current and future therapies With Prof. Philip Newsome is an episode from Diabetes Knowledge into Practice Podcast by Liberum IME.

This episode is 00:14:16 long.

This episode was published on Jun 7, 2022.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Diabetes Knowledge into Practice Podcast when more episodes are available from the podcast feed.